Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{30aac553127f4d3186ee3399ab2b0c2d,
title = "A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification",
abstract = "Sudden cardiac death (SCD) is responsible for a large proportion of non-traumatic, sudden and unexpected deaths in young individuals. Sudden cardiac death is a known manifestation of several inherited cardiac diseases. In post-mortem examinations, about two-thirds of the SCD cases show structural abnormalities at autopsy. The remaining cases stay unexplained after thorough investigations and are referred to as sudden unexplained deaths. A routine forensic investigation of the SCD victims in combination with genetic testing makes it possible to establish a likely diagnosis in some of the deaths previously characterized as unexplained. Additionally, a genetic diagnose in a SCD victim with a structural disease may not only add to the differential diagnosis, but also be of importance for pre-symptomatic family screening. In the case of SCD, the optimal establishment of the cause of death and management of the family call for standardized post-mortem procedures, genetic screening, and family screening. Studies of genetic testing in patients with primary arrhythmia disorders or cardiomyopathies and of victims of SCD presumed to be due to primary arrhythmia disorders or cardiomyopathies, were systematically identified and reviewed. The frequencies of disease-causing mutation were on average between 16 and 48% in the cardiac patient studies, compared with ∼10% in the post-mortem studies. The frequency of pathogenic mutations in heart genes in cardiac patients is up to four-fold higher than that in SCD victims in a forensic setting. Still, genetic investigation of SCD victims is important for the diagnosis and the possible investigation of relatives at risk.",
keywords = "Arrhythmias, Cardiac, Arrhythmogenic Right Ventricular Dysplasia, Brugada Syndrome, Cardiomyopathies, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Familial, Death, Sudden, Cardiac, Heart Arrest, Humans, Long QT Syndrome, Mutation, Phenotype, Tachycardia, Ventricular",
author = "Hertz, {Christin L} and Laura Ferrero-Miliani and Rune Frank-Hansen and Niels Morling and Henning Bundgaard",
note = "Published on behalf of the European Society of Cardiology. All rights reserved. {\textcopyright} The Author 2014. For permissions please email: journals.permissions@oup.com.",
year = "2015",
month = mar,
doi = "10.1093/europace/euu210",
language = "English",
volume = "17",
pages = "350--7",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - JOUR

T1 - A comparison of genetic findings in sudden cardiac death victims and cardiac patients

T2 - the importance of phenotypic classification

AU - Hertz, Christin L

AU - Ferrero-Miliani, Laura

AU - Frank-Hansen, Rune

AU - Morling, Niels

AU - Bundgaard, Henning

N1 - Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.

PY - 2015/3

Y1 - 2015/3

N2 - Sudden cardiac death (SCD) is responsible for a large proportion of non-traumatic, sudden and unexpected deaths in young individuals. Sudden cardiac death is a known manifestation of several inherited cardiac diseases. In post-mortem examinations, about two-thirds of the SCD cases show structural abnormalities at autopsy. The remaining cases stay unexplained after thorough investigations and are referred to as sudden unexplained deaths. A routine forensic investigation of the SCD victims in combination with genetic testing makes it possible to establish a likely diagnosis in some of the deaths previously characterized as unexplained. Additionally, a genetic diagnose in a SCD victim with a structural disease may not only add to the differential diagnosis, but also be of importance for pre-symptomatic family screening. In the case of SCD, the optimal establishment of the cause of death and management of the family call for standardized post-mortem procedures, genetic screening, and family screening. Studies of genetic testing in patients with primary arrhythmia disorders or cardiomyopathies and of victims of SCD presumed to be due to primary arrhythmia disorders or cardiomyopathies, were systematically identified and reviewed. The frequencies of disease-causing mutation were on average between 16 and 48% in the cardiac patient studies, compared with ∼10% in the post-mortem studies. The frequency of pathogenic mutations in heart genes in cardiac patients is up to four-fold higher than that in SCD victims in a forensic setting. Still, genetic investigation of SCD victims is important for the diagnosis and the possible investigation of relatives at risk.

AB - Sudden cardiac death (SCD) is responsible for a large proportion of non-traumatic, sudden and unexpected deaths in young individuals. Sudden cardiac death is a known manifestation of several inherited cardiac diseases. In post-mortem examinations, about two-thirds of the SCD cases show structural abnormalities at autopsy. The remaining cases stay unexplained after thorough investigations and are referred to as sudden unexplained deaths. A routine forensic investigation of the SCD victims in combination with genetic testing makes it possible to establish a likely diagnosis in some of the deaths previously characterized as unexplained. Additionally, a genetic diagnose in a SCD victim with a structural disease may not only add to the differential diagnosis, but also be of importance for pre-symptomatic family screening. In the case of SCD, the optimal establishment of the cause of death and management of the family call for standardized post-mortem procedures, genetic screening, and family screening. Studies of genetic testing in patients with primary arrhythmia disorders or cardiomyopathies and of victims of SCD presumed to be due to primary arrhythmia disorders or cardiomyopathies, were systematically identified and reviewed. The frequencies of disease-causing mutation were on average between 16 and 48% in the cardiac patient studies, compared with ∼10% in the post-mortem studies. The frequency of pathogenic mutations in heart genes in cardiac patients is up to four-fold higher than that in SCD victims in a forensic setting. Still, genetic investigation of SCD victims is important for the diagnosis and the possible investigation of relatives at risk.

KW - Arrhythmias, Cardiac

KW - Arrhythmogenic Right Ventricular Dysplasia

KW - Brugada Syndrome

KW - Cardiomyopathies

KW - Cardiomyopathy, Dilated

KW - Cardiomyopathy, Hypertrophic, Familial

KW - Death, Sudden, Cardiac

KW - Heart Arrest

KW - Humans

KW - Long QT Syndrome

KW - Mutation

KW - Phenotype

KW - Tachycardia, Ventricular

U2 - 10.1093/europace/euu210

DO - 10.1093/europace/euu210

M3 - Journal article

C2 - 25345827

VL - 17

SP - 350

EP - 357

JO - Europace

JF - Europace

SN - 1099-5129

IS - 3

ER -

ID: 46172725